ClearCare
+102%
est. 2Y upside i
Rank
#397
Sector
Healthtech Software
Est. Liquidity
~2Y
Data Quality
Data: LowClearCare is already a subsidiary of WellSky (acquired 2019), so the equity analysis is hypothetical.
Last updated: July 19, 2026
ClearCare capitalizes on the growing home care software market, achieving a 7.5x revenue multiple on $12.16M revenue by year 2, driven by post-pandemic digitization. Exit valuation of $91.5M yields 200% upside for common stock (capped by stage).
ClearCare maintains steady growth in line with market, exiting at 6.5x revenue multiple (within comp range) on $12.16M revenue, implying $79M exit and 159% upside, though preference stack reduces common's share.
ClearCare faces competitive pressure and fails to grow, compressing its multiple to 3x. Exit valuation of $36.5M falls below total funding of $75.6M, resulting in zero proceeds for common stock (-100% return).
Preference Stack Risk
severeFunding Intensity
248%Total funding of $75.6M exceeds current valuation of $30.5M, creating a 2.5x preference overhang. Any exit below $75.6M wipes out common stock.
Dilution Risk
highCompany raised multiple rounds (Series A-D) with 75.6M total funding, indicating significant historical dilution. Future dilution unlikely due to acquisition by WellSky.
Secondary Liquidity
noneNo secondary market activity; company was acquired in 2019.
Last updated: February 22, 2026
Questions to Ask at the Interview
Strategic questions based on ClearCare's data — designed to show you've done your homework.
- 1
“How does ClearCare's acquisition by WellSky affect its long-term product roadmap and go-to-market strategy?”
- 2
“What are the main drivers of revenue retention and upsell within ClearCare's existing customer base?”
- 3
“What is the current 409A valuation of WellSky's common stock, and what liquidity events are anticipated for employees?”
Community
Valuation Sentiment
Our model estimates +102% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.